{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:28:15Z","timestamp":1774668495474,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Japanese Society for Promotion of Science, KAKENHI","award":["24K12213"],"award-info":[{"award-number":["24K12213"]}]},{"name":"Japanese Society for Promotion of Science, KAKENHI","award":["22K16648"],"award-info":[{"award-number":["22K16648"]}]},{"name":"Japanese Society for Promotion of Science, KAKENHI","award":["23H03015"],"award-info":[{"award-number":["23H03015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-024-03165-7","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T23:16:16Z","timestamp":1735600576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of RNF213 p.R4810K variant on postoperative temporal muscle swelling used in encephalo-myo-synangiosis after combined revascularization for Moyamoya disease"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6741-9132","authenticated-orcid":false,"given":"Makoto","family":"Mizushima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8032-7198","authenticated-orcid":false,"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6567-8136","authenticated-orcid":false,"given":"Haruto","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0398-225X","authenticated-orcid":false,"given":"Taku","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0991-0516","authenticated-orcid":false,"given":"Miki","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"issue":"3","key":"3165_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A (1969) Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20(3):288\u2013299. https:\/\/doi.org\/10.1001\/archneur.1969.00480090076012","journal-title":"Arch Neurol"},{"issue":"7","key":"3165_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2176\/jns-nmc.2022-0072","volume":"62","author":"S Kuroda","year":"2022","unstructured":"Kuroda S, Fujimura M, Takahashi JC, Kataoka H, Ogasawara K, Iwama T, Tominaga T, Miyamoto S, Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor, and Welfare, Japan (2022) Diagnostic criteria for Moyamoya disease - 2021 revised version. Neurol Med Chir (Tokyo) 62(7):307\u2013312. https:\/\/doi.org\/10.2176\/jns-nmc.2022-0072","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"3165_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S (2011) A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56(1):34\u201340. https:\/\/doi.org\/10.1038\/jhg.2010.132","journal-title":"J Hum Genet"},{"key":"3165_CR4","doi-asserted-by":"publisher","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE 6:e22542. https:\/\/doi.org\/10.1371\/journal.pone.0022542","journal-title":"PLoS ONE"},{"issue":"11","key":"3165_CR5","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","volume":"45","author":"AC Cecchi","year":"2014","unstructured":"Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RLP, Leal SM, Wang GT, Regalado ES, Steinberg GK, Shendure J, Bamshad MJ, on behalf of University of Washington Center for Mendelian Genomics, Grotta JC, Nickerson DA, Pannu H, Milewicz DM (2014) RNF213 rare variants in an ethnically diverse population with Moyamoya disease. Stroke 45(11):3200\u20133207. https:\/\/doi.org\/10.1161\/STROKEAHA.114.006244","journal-title":"Stroke"},{"issue":"3","key":"3165_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3171\/2016.11.JNS161688","volume":"128","author":"JP Jeon","year":"2018","unstructured":"Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW (2018) Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. J Neurosurg 128(3):793\u2013799. https:\/\/doi.org\/10.3171\/2016.11.JNS161688","journal-title":"J Neurosurg"},{"issue":"12","key":"3165_CR7","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1161\/STROKEAHA.122.039584","volume":"53","author":"VN Nguyen","year":"2022","unstructured":"Nguyen VN, Motiwala M, Elarjani T, Moore KA, Miller LE, Barats M, Goyal N, Elijovich L, Klimo P, Hoit DA, Arthur AS, Morcos JJ, Khan NR (2022) Direct, indirect, and combined extracranial-to-intracranial bypass for adult Moyamoya disease: an updated systematic review and meta-analysis. Stroke 53(12):3572\u20133582. https:\/\/doi.org\/10.1161\/STROKEAHA.122.039584","journal-title":"Stroke"},{"issue":"1 Pt 1","key":"3165_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2176\/nmc.17pt1.29","volume":"17","author":"J Karasawa","year":"1977","unstructured":"Karasawa J, Kikuchi H, Furuse S, Sakaki T, Yoshida Y (1977) A surgical treatment of \u201cmoyamoya\u201d disease \u201cencephalo-myo synangiosis.\u201d Neurol Med Chir (Tokyo) 17(1 Pt 1):29\u201337. https:\/\/doi.org\/10.2176\/nmc.17pt1.29","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"2 Suppl Pediatr","key":"3165_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3171\/ped.2004.100.2.0142","volume":"100","author":"RM Scott","year":"2004","unstructured":"Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA (2004) Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100(2 Suppl Pediatrics):142\u2013149. https:\/\/doi.org\/10.3171\/ped.2004.100.2.0142","journal-title":"J Neurosurg"},{"issue":"11","key":"3165_CR10","doi-asserted-by":"publisher","first-page":"107389","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107389","volume":"32","author":"T Hayashi","year":"2023","unstructured":"Hayashi T, Hara S, Inaji M, Arai Y, Kiyokawa J, Tanaka Y, Nariai T, Maehara T (2023) Long-term prognosis of 452 moyamoya disease patients with and without revascularization under perfusion-based indications. J Stroke Cerebrovasc Dis 32(11):107389. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2023.107389","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"3165_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10143-009-0184-6","volume":"32","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Kaneta T, Shimizu H, Tominaga T (2009) Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease. Neurosurg Rev 32(2):245\u2013249. https:\/\/doi.org\/10.1007\/s10143-009-0184-6","journal-title":"Neurosurg Rev"},{"issue":"6","key":"3165_CR12","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3171\/2018.1.JNS172244","volume":"130","author":"T Machida","year":"2018","unstructured":"Machida T, Higuchi Y, Nakano S, Izumi M, Ishige S, Fujikawa A, Akaogi Y, Shimada J, Ono J (2018) Sagittal splitting of the temporalis muscle for encephalo-myo-synangiosis to prevent ischemic complications due to a swollen temporalis muscle without inhibiting collateral developments in patients with moyamoya disease. J Neurosurg 130(6):1957\u20131964. https:\/\/doi.org\/10.3171\/2018.1.JNS172244","journal-title":"J Neurosurg"},{"key":"3165_CR13","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1016\/j.wneu.2019.09.093","volume":"133","author":"F Kanamori","year":"2020","unstructured":"Kanamori F, Araki Y, Yokoyama K, Uda K, Nishihori M, Izumi T, Okamoto S, Wakabayashi T (2020) Brain compression by encephalo-myo-synangiosis is a risk factor for transient neurological deficits after surgical revascularization in pediatric patients with moyamoya disease. World Neurosurg 133:e558\u2013e566. https:\/\/doi.org\/10.1016\/j.wneu.2019.09.093","journal-title":"World Neurosurg"},{"issue":"7","key":"3165_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2176\/jns-nmc.2023-0008","volume":"63","author":"M Mizushima","year":"2023","unstructured":"Mizushima M, Ito M, Fujima N, Uchino H, Sugiyama T, Fujimura M (2023) Chronological volume changes of the temporal muscle pedicle used for encephalo-myo-synangiosis in combined revascularization for moyamoya disease: a prospective observational study. Neurol Med Chir (Tokyo) 63(7):304\u2013312. https:\/\/doi.org\/10.2176\/jns-nmc.2023-0008","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"6","key":"3165_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.surneu.2006.10.076","volume":"72","author":"H Touho","year":"2009","unstructured":"Touho H (2009) Cerebral ischemia due to compression of the brain by ossified and hypertrophied muscle used for encephalomyosynangiosis in childhood moyamoya disease. Surg Neurol 72(6):725\u2013727. https:\/\/doi.org\/10.1016\/j.surneu.2006.10.076","journal-title":"Surg Neurol"},{"issue":"4","key":"3165_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","volume":"62","author":"M Fujimura","year":"2022","unstructured":"Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, Miyamoto S, Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor Welfare, Japan, Guideline Committee 2021 of the Japan Stroke Society (2022) 2021 Japanese guidelines for the management of Moyamoya disease: guidelines from the research committee on Moyamoya disease and Japan stroke society. Neurol Med Chir (Tokyo) 62(4):165\u2013170. https:\/\/doi.org\/10.2176\/jns-nmc.2021-0382","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"5","key":"3165_CR17","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/STROKEAHA.113.004386","volume":"45","author":"S Miyamoto","year":"2014","unstructured":"Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC, JAM Trial Investigators (2014) Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 45(5):1415\u20131421. https:\/\/doi.org\/10.1161\/STROKEAHA.113.004386","journal-title":"Stroke"},{"issue":"3","key":"3165_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.23736\/s0390-5616.20.05079-1","volume":"65","author":"M Fujimura","year":"2021","unstructured":"Fujimura M, Tominaga T (2021) Flow-augmentation bypass for moyamoya disease. J Neurosurg Sci 65(3):277\u2013286. https:\/\/doi.org\/10.23736\/s0390-5616.20.05079-1","journal-title":"J Neurosurg Sci"},{"issue":"5","key":"3165_CR19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1159\/000336765","volume":"33","author":"M Fujimura","year":"2012","unstructured":"Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T (2012) Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis 33(5):436\u2013445. https:\/\/doi.org\/10.1159\/000336765","journal-title":"Cerebrovasc Dis"},{"issue":"5","key":"3165_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/01.STR.0000162714.46038.0f","volume":"36","author":"HK Sucu","year":"2005","unstructured":"Sucu HK, Gokmen M, Gelal F (2005) The value of XYZ\/2 technique compared with computer-assisted volumetric analysis to estimate the volume of chronic subdural hematoma. Stroke 36(5):998\u20131000. https:\/\/doi.org\/10.1161\/01.STR.0000162714.46038.0f","journal-title":"Stroke"},{"issue":"2","key":"3165_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1227\/NEU.0000000000001201","volume":"80","author":"H Uchino","year":"2017","unstructured":"Uchino H, Kim JH, Fujima N, Kazumata K, Ito M, Nakayama N, Kuroda S, Houkin K (2017) Synergistic interactions between direct and indirect bypasses in combined procedures: the significance of indirect bypasses in moyamoya disease. Neurosurgery 80(2):201\u2013209. https:\/\/doi.org\/10.1227\/NEU.0000000000001201","journal-title":"Neurosurgery"},{"issue":"3","key":"3165_CR22","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s10143-022-01749-9","volume":"45","author":"M Ito","year":"2022","unstructured":"Ito M, Kawabori M, Sugiyama T, Tokairin K, Tatezawa R, Uchino H, Kazumata K, Houkin K, Fujimura M (2022) Impact of RNF213 founder polymorphism (p.R4810K) on the postoperative development of indirect pial synangiosis after direct\/indirect combined revascularization surgery for adult Moyamoya disease. Neurosurg Rev 45(3):2305\u20132313. https:\/\/doi.org\/10.1007\/s10143-022-01749-9","journal-title":"Neurosurg Rev"},{"issue":"2","key":"3165_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000526089","volume":"52","author":"M Kawabori","year":"2023","unstructured":"Kawabori M, Ito M, Kazumata K, Tokairin K, Hatanaka KC, Ishikawa S, Houkin K, Fujimura M (2023) Impact of RNF213 c.14576G>A variant on the development of direct and indirect revascularization in pediatric moyamoya disease. Cerebrovasc Dis 52(2):171\u2013176. https:\/\/doi.org\/10.1159\/000526089","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"3165_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00701-024-06075-1","volume":"166","author":"K Kurisu","year":"2024","unstructured":"Kurisu K, Osanai T, Morishima Y, Ito M, Uchino H, Sugiyama T, Fujimura M (2024) Systemic immune-inflammation index in dural arteriovenous fistula: a feasible biomarker reflecting its clinical characteristics. Acta Neurochir (Wien) 166(1):180. https:\/\/doi.org\/10.1007\/s00701-024-06075-1","journal-title":"Acta Neurochir (Wien)"},{"key":"3165_CR25","unstructured":"Yamamoto T, Uchino H, Ito M, Sugiyama T, Fujimura M (n.d.) Systemic immune-inflammation index is associated with symptomatic cerebral hyperperfusion after revascularization surgery in moyamoya disease. Neurol Med Chir (Tokyo), in press"},{"issue":"11","key":"3165_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N (2012) Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78(11):803\u2013810. https:\/\/doi.org\/10.1212\/WNL.0b013e318249f71f","journal-title":"Neurology"},{"key":"3165_CR27","doi-asserted-by":"publisher","first-page":"106071","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106071","volume":"30","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang Z, Wang X, Zou Z, Ta N, Hao F, Yang Y, Li D, Liang M, Han C, Bao X, Ou L, Wang H, Yang Z, Yang R, Zeng F, Shang M, Nie F, Liu W, Duan L (2021) Validation and extension study exploring the role of RNF213 p.R4810K in 2,877 Chinese moyamoya disease patients. J Stroke Cerebrovasc Dis 30:106071. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.106071","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3165_CR28","doi-asserted-by":"publisher","unstructured":"Sasagasako T, Mineharu Y, Funaki T, Fushimi Y, Chihara H, Park S, Nakajima K, Matsui Y, Okawa M, Kikuchi T, Arakawa Y (2024) RNF213 Mutation associated with the progression from middle cerebral artery steno-occlusive disease to Moyamoya disease. Transl Stroke Res. https:\/\/doi.org\/10.1007\/s12975-024-01293-2. Online ahead of print","DOI":"10.1007\/s12975-024-01293-2"},{"key":"3165_CR29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ene.14184","volume":"27","author":"P Ge","year":"2020","unstructured":"Ge P, Zhang Q, Ye X, Liu X, Deng X, Wang J, Wang R, Zhang Y, Zhang D, Zhao J (2020) Angiographic characteristics in Moyamoya disease with the p. R4810K variant: a propensity score-matched analysis. Eur J Neurol 27:856\u2013863. https:\/\/doi.org\/10.1111\/ene.14184","journal-title":"Eur J Neurol"},{"issue":"4","key":"3165_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3171\/2021.3.JNS203913","volume":"136","author":"Y Mineharu","year":"2021","unstructured":"Mineharu Y, Takagi Y, Koizumi A, Morimoto T, Funaki T, Hishikawa T, Araki Y, Hasegawa H, Takahashi JC, Kuroda S, Houkin K, Miyamoto S (2021) Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease: the first report from the SUPRA Japan Study Group. J Neurosurg 136(4):1005\u20131014. https:\/\/doi.org\/10.3171\/2021.3.JNS203913","journal-title":"J Neurosurg"},{"issue":"1","key":"3165_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10143-023-02030-3","volume":"46","author":"H Uchino","year":"2023","unstructured":"Uchino H, Ito M, Tokairin K, Tatezawa R, Sugiyama T, Kazumata K, Fujimura M (2023) Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease: possible involvement of intrinsic vascular vulnerability. Neurosurg Rev 46(1):119. https:\/\/doi.org\/10.1007\/s10143-023-02030-3","journal-title":"Neurosurg Rev"},{"issue":"2","key":"3165_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3171\/2020.6.JNS201037","volume":"135","author":"R Tashiro","year":"2021","unstructured":"Tashiro R, Fujimura M, Katsuki M, Nishizawa T, Tomata Y, Niizuma K, Tominaga T (2021) Prolonged\/delayed cerebral hyperperfusion in adult patients with moyamoya disease with RNF213 gene polymorphism c.14576G>A (rs112735431) after superficial temporal artery-middle cerebral artery anastomosis. J Neurosurg 135(2):417\u2013424. https:\/\/doi.org\/10.3171\/2020.6.JNS201037","journal-title":"J Neurosurg"},{"key":"3165_CR33","doi-asserted-by":"publisher","unstructured":"Torazawa S, Miyawaki S, Imai H, Hongo H, Ono H, Ogawa S, Sakai Y, Kiyofuji S, Koizumi S, Komura D, Katoh H, Ishikawa S, Saito N (2024) Association of genetic variants with postoperative donor artery development in moyamoya disease: RNF213 and other moyamoya angiopathy-related gene analysis. Transl Stroke Res. https:\/\/doi.org\/10.1007\/s12975-024-01248-7. Online ahead of print","DOI":"10.1007\/s12975-024-01248-7"},{"issue":"6","key":"3165_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3171\/2023.8.PEDS23304","volume":"32","author":"EY Zheng","year":"2023","unstructured":"Zheng EY, Hara S, Inaji M, Tanaka Y, Nariai T, Maehara T (2023) Regression of periventricular anastomosis after indirect revascularization in pediatric patients with moyamoya disease. J Neurosurg 32(6):719\u2013728. https:\/\/doi.org\/10.3171\/2023.8.PEDS23304","journal-title":"J Neurosurg"},{"issue":"1\u20132","key":"3165_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000503250","volume":"48","author":"P Ge","year":"2019","unstructured":"Ge P, Ye X, Liu X, Deng X, Wang J, Wang R, Zhang Y, Zhang D, Zhang Q, Zhao J (2019) Association between p.R4810K variant and postoperative collateral formation in patients with moyamoya disease. Cerebrovasc Dis 48(1\u20132):77\u201384. https:\/\/doi.org\/10.1159\/000503250","journal-title":"Cerebrovasc Dis"},{"key":"3165_CR36","doi-asserted-by":"publisher","first-page":"687088","DOI":"10.3389\/fneur.2021.687088","volume":"12","author":"Y Mineharu","year":"2021","unstructured":"Mineharu Y, Miyamoto S (2021) RNF213 and GUCY1A3 in moyamoya disease: key regulators of metabolism, inflammation, and vascular stability. Front Neurol 12:687088. https:\/\/doi.org\/10.3389\/fneur.2021.687088","journal-title":"Front Neurol"},{"issue":"3","key":"3165_CR37","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbrc.2020.02.024","volume":"525","author":"M Takeda","year":"2020","unstructured":"Takeda M, Tezuka T, Kim M, Choi J, Oichi Y, Kobayashi H, Harada KH, Mizushima T, Taketani S, Koizumi A, Youssefian S (2020) Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NF\u03baB activation and apoptosis in an AAA+ domain-dependent manner. Biochem Biophys Res Commun 525(3):668\u2013674. https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.024","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3165_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1227\/00006123-199209000-00003","volume":"31","author":"T Matsushima","year":"1992","unstructured":"Matsushima T, Inoue T, Suzuki SO, Fujii K, Fukui M, Hasuo K (1992) Surgical treatment of moyamoya disease in pediatric patients\u2013comparison between the results of indirect and direct revascularization procedures. Neurosurgery 31(3):401\u2013405. https:\/\/doi.org\/10.1227\/00006123-199209000-00003","journal-title":"Neurosurgery"},{"issue":"6","key":"3165_CR39","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/01.str.28.6.1170","volume":"28","author":"T Ishikawa","year":"1997","unstructured":"Ishikawa T, Houkin K, Kamiyama H, Abe H (1997) Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke 28(6):1170\u20131173. https:\/\/doi.org\/10.1161\/01.str.28.6.1170","journal-title":"Stroke"},{"issue":"7","key":"3165_CR40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00381-007-0551-y","volume":"24","author":"M Fujimura","year":"2008","unstructured":"Fujimura M, Kaneta T, Tominaga T (2008) Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease. Childs Nerv Syst 24(7):827\u2013832. https:\/\/doi.org\/10.1007\/s00381-007-0551-y","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"3165_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10143-016-0734-7","volume":"39","author":"S Rashad","year":"2016","unstructured":"Rashad S, Fujimura M, Niizuma K, Endo H, Tominaga T (2016) Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management. Neurosurg Rev 39(4):615\u2013623. https:\/\/doi.org\/10.1007\/s10143-016-0734-7","journal-title":"Neurosurg Rev"},{"key":"3165_CR42","doi-asserted-by":"crossref","unstructured":"Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, Kuroda S, Yamada K, Miyamoto S, on behalf of the JAM Trial Investigators (2016) Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial. Stroke 47(1):37\u201343. https:\/\/www.ahajournals.org\/doi\/epub\/10.1161\/STROKEAHA.115.010819","DOI":"10.1161\/STROKEAHA.115.010819"},{"issue":"4","key":"3165_CR43","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.surneu.2008.02.031","volume":"71","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T (2009) Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71(4):442\u2013447. https:\/\/doi.org\/10.1016\/j.surneu.2008.02.031","journal-title":"Surg Neurol"},{"issue":"Suppl 2","key":"3165_CR44","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1016\/s0303-8467(97)00075-9","volume":"99","author":"K Houkin","year":"1997","unstructured":"Houkin K, Ishikawa T, Yoshimoto T, Abe H (1997) Direct and indirect revascularization for Moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg 99(Suppl 2):S142-145. https:\/\/doi.org\/10.1016\/s0303-8467(97)00075-9","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"3165_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000520801","volume":"51","author":"A Kanoke","year":"2022","unstructured":"Kanoke A, Fujimura M, Tashiro R, Ozaki D, Tominaga T (2022) Transient global cerebral hypoperfusion as a characteristic cerebral hemodynamic pattern in the acute stage after combined revascularization surgery for pediatric moyamoya disease: N-Isopropyl-P-[123I] iodoamphetamine single-photon emission computed tomography study. Cerebrovasc Dis 51(4):453\u2013460. https:\/\/doi.org\/10.1159\/000520801","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"3165_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1227\/NEU.0000000000000238","volume":"74","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, Tominaga T (2014) Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery 74(2):163\u2013170. https:\/\/doi.org\/10.1227\/NEU.0000000000000238","journal-title":"Neurosurgery"},{"issue":"7","key":"3165_CR47","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/STROKEAHA.116.013304","volume":"47","author":"H Uchino","year":"2016","unstructured":"Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K (2016) Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke 47(7):1930\u20131932. https:\/\/doi.org\/10.1161\/STROKEAHA.116.013304","journal-title":"Stroke"},{"issue":"1","key":"3165_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3171\/2023.8.PEDS23295","volume":"33","author":"K Ishii","year":"2023","unstructured":"Ishii K, Kanamori F, Araki Y, Uda K, Yokoyama K, Mamiya T, Takayanagi K, Goto S, Nishihori M, Izumi T, Saito R (2023) Effect of thin-split encephalomyosynangiosis on transient neurological events in revascularization surgery for pediatric patients with moyamoya disease. J Neurosurg Pediatr 33(1):29\u201334. https:\/\/doi.org\/10.3171\/2023.8.PEDS23295","journal-title":"J Neurosurg Pediatr"},{"key":"3165_CR49","doi-asserted-by":"publisher","unstructured":"Navarro R, Chao K, Gooderham PA, Bruzoni M, Dutta S, Steinberg GK (2014) Less invasive pedicled omental-cranial transposition in pediatric patients with Moyamoya disease and failed prior revascularization. Neurosurgery (Suppl 1):1\u201314. https:\/\/doi.org\/10.1227\/NEU.0000000000000119","DOI":"10.1227\/NEU.0000000000000119"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-03165-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-024-03165-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-03165-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:20:24Z","timestamp":1772079624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-024-03165-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3165"],"URL":"https:\/\/doi.org\/10.1007\/s10143-024-03165-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5161717\/v1","asserted-by":"object"}]},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board in our institute (approval number: 014-053, approval date: November 25, 2014). This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants or the legal guardians of patients aged\u2009<\u200918 years.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}